Clinical trial
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis
NCT03481842 is registered in ClinicalTrials.gov with BioGene Pharmaceutical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis
- Lead sponsor
- BioGene Pharmaceutical Ltd.
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- October 10, 2021
- Completion date
- October 10, 2021
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometriosis, endometriosis externa, endometriosis ovary, endometriosis, rectum